(a) One or more compassionate-use institutional review boards may be established to:
(1) evaluate and approve proposed research programs to study the medical use of low-THC cannabis in treating a medical condition designated by rule of the executive commissioner under Section 487.252(a); and
(2) oversee patient treatment undertaken as part of an approved research program, including the certification of treating physicians.
(b) An institutional review board must be affiliated with a dispensing organization and meet one of the following conditions:
(1) be affiliated with a medical school, as defined by Section 61.501, Education Code;
(2) be affiliated with a hospital licensed under Chapter 241 that has at least 150 beds;
(3) be accredited by the Association for the Accreditation of Human Research Protection Programs;
(4) be registered by the United States Department of Health and Human Services, Office for Human Research Protections, in accordance with 21 C.F.R. Part 56; or
(5) be accredited by a national accreditation organization acceptable to the Texas Medical Board.